Cargando…
Azithromycin: An Underappreciated Quinolone-Sparing Oral Treatment for Pseudomonas aeruginosa Infections
Outpatient treatment of Pseudomonas aeruginosa infections is challenged by increasing rates of resistance to fluoroquinolones, the only class of antibiotics which offers an established oral route of administration against this organism. Azithromycin does not demonstrate activity against P. aeruginos...
Autores principales: | Ulloa, Erlinda R., Sakoulas, George |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9024921/ https://www.ncbi.nlm.nih.gov/pubmed/35453266 http://dx.doi.org/10.3390/antibiotics11040515 |
Ejemplares similares
-
Susceptibility Rates of Pseudomonas Aeruginosa Strains to Quinolones
por: Adhikari, Luna, et al.
Publicado: (2010) -
Antivirulence activity of azithromycin in Pseudomonas aeruginosa
por: Imperi, Francesco, et al.
Publicado: (2014) -
Differentiation in Quinolone Resistance by Virulence Genotype in Pseudomonas aeruginosa
por: Agnello, Melissa, et al.
Publicado: (2012) -
255. Ticagrelor Aids Platelet-Mediated Clearance in a Refractory Staphylococcus aureus Endovascular Infection with Septic Emboli
por: Ulloa, Erlinda, et al.
Publicado: (2020) -
Surface-Growing Communities of Pseudomonas aeruginosa Exhibit Distinct Alkyl Quinolone Signatures
por: Morales-Soto, Nydia, et al.
Publicado: (2018)